FDA Issues Safety Alert for Texas Compounder’s Products

The FDA is warning healthcare professionals that certain drugs from Texas-based Specialty Compounding could cause a bacterial bloodstream infection, becoming the latest safety incident to befall the scrutinized compounding industry. The agency has received 15 adverse event reports from patients in two hospitals.
Drug GMP Report